Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Fish and Richardson
US Department of Justice
Chubb
Healthtrust
Fuji
Argus Health
Boehringer Ingelheim
Deloitte
McKesson

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205874

« Back to Dashboard
NDA 205874 describes AURYXIA, which is a drug marketed by Keryx Biopharms and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug. Additional details are available on the AURYXIA profile page.

The generic ingredient in AURYXIA is ferric citrate. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ferric citrate profile page.

Summary for NDA: 205874

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:14
Formulation / Manufacturing:see details

Pharmacology for NDA: 205874

Ingredient-typeIron
Mechanism of ActionPhosphate Chelating Activity

Suppliers and Packaging for NDA: 205874

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AURYXIA
ferric citrate
TABLET;ORAL 205874 NDA Keryx Biopharmaceuticals, Inc. 59922-631 59922-631-01 200 TABLET, COATED in 1 BOTTLE (59922-631-01)
AURYXIA
ferric citrate
TABLET;ORAL 205874 NDA Keryx Biopharmaceuticals, Inc. 59922-631 59922-631-91 200 TABLET, COATED in 1 BOTTLE (59922-631-91)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 210MG IRON
Approval Date:Sep 5, 2014TE:RLD:Yes
Patent:► SubscribePatent Expiration:Feb 3, 2017Product Flag?YSubstance Flag?Delist Request?
Patented Use:CONTROL OF SERUM PHOSPHOROUS LEVELS
Patent:► SubscribePatent Expiration:Feb 18, 2024Product Flag?YSubstance Flag?YDelist Request?
Patent:► SubscribePatent Expiration:Apr 21, 2026Product Flag?Substance Flag?Delist Request?
Patented Use:CONTROL OF SERUM PHOSPHOROUS LEVELS

Expired Orange Book Patents for NDA: 205874

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Keryx Biopharms
AURYXIA
ferric citrate
TABLET;ORAL205874-001Sep 5, 2014► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cerilliant
Fuji
Merck
Novartis
QuintilesIMS
Medtronic
Moodys
Covington
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot